bioRxivSynthetic BiologyPreprint
Highly enhanced transgene integration in human pluripotent stem cells by serine integrase BxbI
Abstract
Genome engineering and especially integration of large DNA payloads in human pluripotent stem cells (hPSC) remains challenging largely due to the sensitive nature of hPSCs. Site specific recombinases such as the serine integrase Bxb1 have been utilised successfully to target hPSC, however the targeting efficiencies remain low. Here we leveraged codon optimisation, inclusion of a nuclear localisation signal, mRNA modality and co-introduction of p53 dominant negative fragment to increase the transgene payload integration efficiency by up to 20-fold in defined genomic safe harbours in hPSCs.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Site-specific integration of transposon via engineered piggyBac transposase
Naiqing Xu, Lei Han, … Xiaoyang Wu·bioRxiv·Jan 21, 2026
- A Flexible Transgene Integration Landing-Pad Toolkit in Human Induced Pluripotent Stem Cells Enables Facile Cellular Engineering, Gene Zygosity Control, and Parallel Transgene Integration
Aaron H. Rosenstein, Maria H. T. Nguyen, … Michael Garton·bioRxiv·Mar 3, 2023
- STRAIGHT-IN: A platform for high-throughput targeting of large DNA payloads into human pluripotent stem cells
C. Grandela, A. Blanch-Asensio, … R. P. Davis·bioRxiv·Dec 8, 2021
- Highly efficient scarless knock-in of reporter genes into human and mouse pluripotent stem cells via transient antibiotic selection
V. M. Sluch, X. Chamling, … D. J. Zack·bioRxiv·Jul 23, 2018
- ONE-STEP tagging: a versatile method for rapid site-specific integration by simultaneous reagent delivery
Valentina Migliori, Michaela Bianka Bruntraeger, … Andrew Roger Bassett·Nucleic Acids ResearchPeer-reviewed·Aug 6, 2025
- Versatile and efficient non-viral integration of large transgenes in human T cells via CRISPR knock-in and engineered integrases
Isabell Kassing, Jonas Kath, … Dimitrios L. Wagner·bioRxiv·Sep 10, 2025